Paratek to Present Omadacycline Microbiologic, Pharmacokinetic and Clinical Data at ASM Microbe 2016
13 juin 2016 16h01 HE
|
Paratek Pharmaceuticals
- Biofilm, post-antibiotic effects, microbiologic surveillance and omadacycline in vitro activity against select pathogens to be presented - Clinical PK and Modelling Strategies for omadacycline to...
ContraFect Announces Presentation of Data at ASM Microbe 2016
08 juin 2016 07h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - June 08, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...